scholarly journals Lived time and the affordances of clinical research participation

Author(s):  
Natassia Brenman ◽  
Richard Milne
2011 ◽  
Vol 1 (12) ◽  
pp. 1663-1668 ◽  
Author(s):  
Anne S Lindblad ◽  
Pam Zingeser ◽  
Nil Sismanyazici-Navaie

Author(s):  
Fiona Ecarnot ◽  
Romain Chopard ◽  
Francois Schiele ◽  
Nicolas Meneveau

Introduction: Guidelines rely on evidence-based data, and clinical research is key to providing this evidence-base. Yet the factors that influence a patient’s decision to participate (or not) in research remain poorly documented. We aimed to investigate the factors that determine the decision to accept or decline clinical trial participation, using a qualitative approach. Methods: Single-centre, qualitative study using semi-directive interviews with patients (pts) who had been invited to participate in a randomized clinical trial and who had given their decision. Both pts who refused and pts who accepted were included. There were no inclusion criteria; all pts who met the inclusion criteria of the selected trial and had been approached for consent were eligible. Pts also completed a questionnaire rating 16 statements examining reasons for accepting or declining trial entry. Verbatim from the interviews were analysed using a grounded theory (GT) approach. Results: To date, 14 patients have been interviewed; average age 75±7 years. Two pts did not know if they were currently participating in a trial or not; 1 said he was not participating although he had provided consent. From a GT perspective, the main concern of patients does not appear to be the question of research participation, but rather the fact of being sick, and their overriding preoccupation is how to return to their previous state of wellbeing and overcome the current acute episode. Regarding the decision to participate in research, the main themes that arose were: (1) the positive value of the trial for the patient (benefitting from the intervention; interest in receiving closer and/or more regular follow-up due to trial participation), although some pts clearly do not understand the concept of randomization; (2) the level of engagement in the process of care (some pts do not bother to read the information given to them, but just accept what is proposed without question, while others decline immediately without reading trial information). Two dimensions emerge, namely physical and emotional health, with a spectrum ranging from fragile to robust. Where the patient is situated on this spectrum appears to influence their attitude towards research participation. Conclusions: The decision to participate (or not) in clinical research appears to be more related to the patient’s general behaviour and attitude when sick, rather than any specific trial-related constraints or advantages. The level of comprehension of pts who have been through the consent process casts a doubt on the “informed” character of the consent.


2010 ◽  
Vol 76 (7) ◽  
pp. 741-742 ◽  
Author(s):  
Carla Fisher ◽  
Megan K. Baker

At a university-based general surgery training program, post-graduate year (PGY) to 5 categorical general surgery residents had been required to complete an annual clinical research project and a year of laboratory research. Since the 80-hour work week, the laboratory experience was made optional, with a resultant decline in laboratory and clinical participation by 50 per cent and 75 per cent, respectively. Our goal was to review the effect of a simple programmatic intervention on the research compliance rate and quality. The Department was informed about the clinical research requirement via e-mail, memo, and announcements. Faculty submitted lists of novel or on-going projects. This was compiled and e-mailed to the Department with a list of project milestones. This included identification of a research mentor and project, Human Subjects Course certification, institutional review board submission dates, a midyear progress report, and final submission date. Rates of compliance and nature of research were recorded the year before and the 2 years after the intervention. Before the intervention, 2 of 16 residents were compliant. Faculty submitted 76 projects for resident review. One hundred per cent compliance with all aspects of the program was seen at the end of both year 1 and 2. Case reports rate fell from 65, to 30, to 25 per cent by the end of year 2. Publications increased from three preintervention to 13 by year 2. Presentations increased from five preintervention to 13 by end of year 2. This study demonstrates that small inexpensive interventions can have a dramatic effect on research participation.


2018 ◽  
Vol 28 (13) ◽  
pp. 2033-2047 ◽  
Author(s):  
Kyoko Wada ◽  
Marilyn K. Evans ◽  
Barbra de Vrijer ◽  
Jeff Nisker

Limited clinical research with pregnant women has resulted in insufficient data to promote evidence-informed prenatal care. Charmaz’s constructivist grounded theory methodology was used to explore how research with pregnant women would be determined ethically acceptable from the perspectives of pregnant women, health care providers, and researchers in reproductive sciences. Semistructured interviews were conducted with a purposive sample of 12 pregnant women, 10 health care providers, and nine reproductive science researchers. All three groups suggested the importance of informed consent and that permissible risk would be very limited and complex, being dependent on the personal benefits and risks of each particular study. Pregnant women, clinicians, and researchers shared concerns about the well-being of the woman and her fetus, and expressed a dilemma between promoting research for evidence-informed prenatal care while securing the safety in the course of research participation.


2012 ◽  
Vol 5 (2) ◽  
pp. 137-141
Author(s):  
Susan Doyle-Lindrud

We as a society have all benefited from past research. These benefits include immunizations, antibiotics, antihypertensive, diabetic medication, and many more. Clinical research is ongoing, looking for better treatments, improved technologies, and cures for diseases. Unfortunately, enrollment into these research studies is often low and can become the barrier to completing the study. Why do so few people participate in trials and yet expect researchers to find cures? Should the public benefit from the latest treatments without ever having to participate in the process? Do we have a moral obligation to participate in research or should it be left to the altruistic members of society alone? Differing views of this argument are explored.


2016 ◽  
Vol 42 (12) ◽  
pp. 805-808 ◽  
Author(s):  
Rosalind McDougall ◽  
Dominique Martin ◽  
Lynn Gillam ◽  
Nina Hallowell ◽  
Alison Brookes ◽  
...  

Ethical concerns about therapeutic misconception have been raised since the early 1980s. This concept was originally described as research participants' assumptions that decisions relating to research interventions are made on the basis of their individual therapeutic needs. The term has since been used to refer to a range of ‘misunderstandings’ that research participants may have. In this paper, we describe a new concept—therapeutic appropriation. Therapeutic appropriation occurs when patients, or clinicians, actively reframe research participation as an opportunity to enhance patients' clinical care, while simultaneously acknowledging the generalised research aims. To illustrate the concept of therapeutic appropriation, we draw on data from an interview study which we conducted to investigate the experiences of patients and general practitioners involved in clinical trials in primary care. We argue that therapeutic appropriation has two key elements: comprehension that the research project is not necessarily aiming to benefit participants and the deliberate use of incidental features of the research for personal therapeutic benefit of various kinds. We conclude that therapeutic appropriation is a useful concept that refines understanding of potential ethical problems in clinical research, and points to strategies to address them.


Sign in / Sign up

Export Citation Format

Share Document